In patients with idiopathic deep vein thrombosis (DVT), CX3CR1-expressing platelet-bound CD8 + lymphocytes are markedly increased and have been proposed as prognostic markers for adverse cardiovascular events (60). This evidence concerns the gene CD8A and deep vein thrombosis.